Medical and Pharmaceutical University of Texas develops lung cancer breath analysis system It identifies 8 volatile organic compounds associated with thoracic cancers Rowan Dunne2 days ago
Medical and Pharmaceutical Bangladesh school pioneers unique lung cancer breath test It harnesses the power of aluminum-derived nanotubes Rowan DunneOctober 15, 2025
Medical and Pharmaceutical Leading experts exchange lung cancer insights at Vietnam conference Biomarker testing, AI and early detection were key topics this year Rowan DunneOctober 14, 2025
Medical and Pharmaceutical University of Calgary needs your toenail clippings for lung cancer research Toenails have been proven to store lead-210: an isotope linked to radon exposure Rowan DunneOctober 8, 2025
Medical and Pharmaceutical Malaysian health professionals celebrate launch of LungShield initiative The program will utilize AI-assisted chest X-ray tech from Qure.ai, low-dose CT scans and tissue sampling Rowan DunneOctober 1, 2025
Medical and Pharmaceutical Guardant Health backs lung cancer screening advocacy campaign The aim is to enhance public understanding about proper screening and biomarker testing diligence Rowan DunneSeptember 30, 2025
Medical and Pharmaceutical Dogs detect lung cancer in breath samples with 78% accuracy, study finds They helped to diagnose dozens of people with the respiratory disease Rowan DunneSeptember 26, 2025
Medical and Pharmaceutical Iran develops lung cancer vaccine with mRNA tech and AI algorithms It can be produced 90% faster than traditional vaccines, according to an Iranian scientist Rowan DunneSeptember 24, 2025
Medical and Pharmaceutical Breath Diagnostics leaders promote their mission at Miami investment conference The National Investment Banking Association's event unites micro and small cap companies with potential investors Rowan DunneSeptember 21, 2025
AI and Autonomy Medical revolution: AI bot ‘Delphi-2M’ can predict your risk of over 1,000 diseases It will provide a timeline showing when a person is most likely to develop a condition Rowan DunneSeptember 18, 2025